Canada markets closed

Evogene Ltd. (EVGN)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.71000.0000 (0.00%)
At close: 04:00PM EDT
0.7316 +0.02 (+3.04%)
After hours: 04:28PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-23,879
-23,879
-26,638
-27,793
-23,374
Depreciation & amortization
2,612
2,612
2,580
2,234
2,727
Deferred income taxes
-33
-33
90
13
32
Stock based compensation
1,877
1,877
1,186
2,609
4,097
Change in working capital
-400
-400
-771
1,656
-1,449
Accounts receivable
-9
-9
-67
-59
-150
Inventory
490
490
-474
-92
0
Accounts Payable
742
742
-469
625
-29
Other working capital
-22,362
-22,362
-24,849
-25,563
-20,196
Other non-cash items
-412
-412
3,100
-873
1,031
Net cash provided by operating activites
-21,577
-21,577
-23,678
-24,716
-19,514
Cash flows from investing activities
Investments in property, plant and equipment
-785
-785
-1,171
-847
-682
Purchases of investments
-10,703
-10,703
-911
-24,114
0
Sales/Maturities of investments
6,924
6,924
15,356
4,395
10,097
Net cash used for investing activites
-4,538
-4,538
13,274
-20,566
9,415
Cash flows from financing activities
Debt repayment
-836
-836
-803
-580
-639
Common stock issued
8,449
8,449
21
29,582
18,658
Other financing activites
10,539
10,539
118
790
307
Net cash used privided by (used for) financing activities
18,152
18,152
9,343
30,276
20,374
Net change in cash
-8,208
-8,208
-3,345
-13,904
11,481
Cash at beginning of period
28,980
28,980
32,325
46,229
34,748
Cash at end of period
20,772
20,772
28,980
32,325
46,229
Free Cash Flow
Operating Cash Flow
-21,577
-21,577
-23,678
-24,716
-19,514
Capital Expenditure
-785
-785
-1,171
-847
-682
Free Cash Flow
-22,362
-22,362
-24,849
-25,563
-20,196